The pandemic has heightened the need to advance health equity and, at Amgen, we continue to build upon our work to advance policies and practices in support of achieving health equity so that all people have an opportunity to be as healthy as possible. One of our strategic pillars…

In the wake of the Taliban taking over Afghanistan and U.S. forces, diplomats, and aid workers pulling out of the country, there are many yet unanswered questions about how exactly the country will approach women’s rights and public health policy as well as the COVID-19 pandemic and diseases like…

Ever since the COVID-19 pandemic began, members of underrepresented and historically underserved communities have been disproportionately impacted by it, including members of the Hispanic and Latinx communities. While 18.5 percent of the U.S. population is Hispanic and Latinx, the community…

September is Sickle Cell Awareness Month—a time to reflect on how many people are affected by Sickle Cell Disease (SCD) and how much more needs to be done to fund research and put an end to it once and for all. However, for Teonna Woolford, every month is Sickle Cell Awareness Month. “As an…

They are not the household names, but the medications they are researching and developing could be the lifeline patients are waiting for. Today we explore how drug price controls—now making their way through Congress—could have unintended consequences for the small biotechs that are the engine of…

The U.S. transportation sector leads all other sectors in greenhouse gas emissions. September 22 is International Car Free day, a day when folks make a pledge to walk or use public transportation with the goal of bringing about clearer skies and less traffic for one day. But what if we didn’t need…

This Hispanic Heritage Month, Good Day BIO will be highlighting the achievements of Hispanic and Latinx individuals who have eliminated barriers in the sciences, medicine, and biotechnology—here’s a list of 25 trailblazers you should know.

For more than a year now, COVID has been society’s focus—and rightly so. But today we turn our attention to another virus—HIV. After 40 years, there is still no cure or a vaccine for the disease. In this episode, we hear from Dr. Anthony Fauci and CEO of innovative company American Gene…

COVID-19 has caused major changes to work, travel, and learning. Whether changes to visa policies impacting foreign workers or foreign students’ ability to study in the United States, the pandemic continues to impact the biotechnology sector. Foreign workers’ jobs are unfilled Visa holders have…

When BIO launched the BIO Equality Agenda last year, its goal was to counteract the systemic inequality, injustice and unfair treatment of underserved communities. Through its three pillars for change – Promote Health Equity, Invest in the Current and Next Generation of Scientists, and Expand…